Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Ранг среди акций #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Цена акции
$4.06
Последняя синхронизация: 2024-02-23
Рыночная капитализация
$145.61M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Theseus Pharmaceuticals, Inc. (THRX)

Категория

История цены акций Theseus Pharmaceuticals, Inc. (THRX)
Наивысшая цена закрытия: $4.07 2024-02-01

Наименьшая цена закрытия: $16.20 2021-10-01
История цены акций Theseus Pharmaceuticals, Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH